跳至主要内容
临床试验/NCT00621920
NCT00621920已完成2 期

Efficacy Study of Bowel Preparation Before Colonoscopy

C.B. Fleet Company, Inc.4 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2008年1月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
72
试验地点
4
主要终点
Effectiveness of bowel cleansing based on a grading scale.

研究概览

简要总结

The purpose of this study is to determine the efficacious dose range when used as a bowel preparation before colonoscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and nonpregnant women who are scheduled for an elective colonoscopy and who are at least 50 years of age.
  • Are able to communicate with study personnel and comply with study requirements.
  • Are able and willing to follow study-specified testing, diet, and hydration regimen.
  • Have been informed of the nature and risks of the study and have given written informed consent.

排除标准

  • Have known or suspected liver disease or any history of abnormal liver function tests.
  • Have clinically active cardiovascular disease within the past 6 months.
  • Have blood pressure greater than 150/90 mm Hg.
  • Have known or suspected renal insufficiency.
  • Have known or suspected electrolyte abnormalities, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon, or ileus.
  • Have a history of prior bowel surgery within 2 years before enrollment, or active inflammatory bowel disease.
  • Have diabetes or a history of diabetes.
  • Have clinical evidence of dehydration.
  • Are pregnant or breast-feeding.
  • Are unwilling to abstain from alcohol consumption from one day before colonoscopy until discharged from the study.
  • Use prohibited medications of the study in the defined timeframes.
  • Have received any investigational agent within 30 days before dosing.
  • Have any known contraindications to the study treatment.
  • Have any known or suspected allergies to the components of the study medication.
  • Have any other condition which would make the subject unsuitable for inclusion in the study.

结局指标

主要结局

Effectiveness of bowel cleansing based on a grading scale.

时间窗: During colonoscopy

次要结局

未报告次要终点

研究者

发起方
C.B. Fleet Company, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验